Health-related quality of life after interventional or conservative strategy in patients with unstable angina or non–ST-segment elevation myocardial infarction: One-year results of the third randomized intervention trial of unstable angina (RITA-3)

Abstract
No abstract available
Funding Information
  • Boston Scientific Corporation
  • Merck
  • British Heart Foundation
  • Medtronic
  • Bristol-Myers Squibb
  • Bayer
  • Schering-Plough